Innovation After Hours: Life Sciences Showcase Event

6 views
Skip to first unread message

Innosphere Ventures

unread,
Apr 17, 2023, 11:44:08 AM4/17/23
to jkef...@larimer.org
Reminder You're invited to a Life Sciences Event

Innovation After Hours:

Showcase & Graduation of the Life Sciences Incubation Program


Hello Startup and Life Sciences Community,


Reminder - You're invited to a special Innovation After Hours event this week showcasing the startup companies who are graduating from the first "Colorado Life Sciences Incubation Program!"


This coming Thursday, April 20th at 3:30pm, attendees will hear short overviews from the graduating companies who are all developing or commercializing technologies, devices, and other life-saving breakthroughs, as well as hear from President and CEO of the Colorado BioScience Association, Elyse Blazevich.


Following presentations, startup companies will showcase their innovative and inspiring work -- allowing attendees to meet the founders and get an even closer look at their products.


This networking event is an opportunity to learn about the latest developments in Colorado's life sciences industry and to connect with professionals, industry leaders and members of our life sciences community. On behalf of Innosphere and the Colorado BioScience Association, we hope you'll be able to join us!

The Life Sciences Incubation Program:

Showcase & Graduation Event

Thursday, April 20th, 2023 | 3:30pm - 7:00pm MST

Location: 320 East Vine Drive, Fort Collins, CO 80524

RSVP Here! Registration Required.

Light snacks, beer, and wine will be provided.

Presenting companies include the graduating startups of:


MicroPure Genomics Inc.

MicroPure Genomics is developing a sample preparation instrument capable of preparing ultra-long to short read samples for genomic sequencing using a rapid, novel approach utilizing its proprietary purification technology, EH Trapping. The state-of-the-art instrument, μPrep, not only automates end-to-end genomic sample preparation but also reduces the preparation time, the man-power burden, and associated cost. Using the µPrep enables unprecedented reliability and length of samples, and consequent sequencing results that will provide insights into the genome that are not currently possible. 

  • Industry Segment: Life Science, Biotech
  • Aurora, Co
  • CEO and Co-Founder: Ryan J Montes
  • Co-Founder: Jason E Butler
  • Founded: 2021
  • www.micropuregenomics.com


DenTriage 

DenTriageTM is a comprehensive mobile and web-based platform that provides a convenient way for patients to receive timely care for urgent dental issues using state-of-the-art Tele-Dentistry capabilities. DenTriage enables consumers to get urgent dental consults promptly, find dentists quickly, and make appointments easily. DenTriage will improve ease of access to dental care, decrease dental-related ER visits, and reduce the overall cost of dental care.

  • Industry Segment: Digital, Oral Health | Teledentistry
  • Aurora, Co
  • Dr. Mehul V. Gandhi, MD. MBA, CEO
  • Founded: 2017
  • www.dentriage.com


SteriO3

SteriO3 provides an innovative solution to the need for surgical instrumentation sterilization in austere field-based environments. The company’s rugged ozone sterilization system the ROSS M1 is a portable, rapid, and easy-to-use system designed specifically to meet the challenges presented when dealing with surgery in conflict zones, after natural disasters or in remote field-based locations. The Broomfield, Colorado-based company was formed in 2017 to commercialize the device by its founder and President Steve Hughes and is pleased to be collaborating with both US Navy and US Air Force.

  • Industry Segment: Medical Device
  • Broomfield, CO
  • Steve Hughes, President
  • Founded: 2017
  • www.sterio3.com


Vitro3D

Vitro3D is a venture-backed spin-out of the University of Colorado Boulder bringing its patented volumetric 3D printing solutions to a number of industries, including life sciences, dental, electronics, hearing, aerospace, and automotive. Vitro3D is reimagining manufacturing by using a proprietary cartridge-based volumetric 3D printing technique to disrupt how parts are fabricated. Vitro3D's technology enables support-free printing of products into a cartridge in a matter of seconds. Their rapid (sub-minute) and high-resolution process allows for the production of parts that have a broader range of material properties, thereby opening new markets for 3D printing. With their groundbreaking achievements, Vitro3D is poised to lead the way in volumetric 3D printing and transform the industry through the production of more complex customized parts in a faster and more cost-effective manner.


Beryl Therapeutics

Beryl is developing a safe drug for the treatment of osteoporosis. 80% of people diagnosed with osteoporosis are untreated because of safety concerns. Beryl’s compound originates from olive oil and can be seen in our bodies - a safety advantage over current bone therapeutics that will disrupt the market and encourage patient adoption and adherence. Unlike current options, the Beryl compound works on both sides of the bone remodeling process – absorbing and forming bone with a net positive for bone formation. Beryl’s compound will provide women safe and effective options to manage their bone health.

  • Industry Segment: Biotechnology
  • Longmont, CO
  • Lisa Padilla, CEO & Co-Founder | Alison B. Lukacsko, CSO & Co-Founder | Allison Drew Klein, Co-Founder
  • Founded: 2018
  • www.beryltherapeutics.com


RedDrop Dx

RedDrop Dx is a developer of low cost, pain-free blood collection, dispensing, and transportation devices which may be used in Point of Care, Home Health, and remote collection situations. The company believes in a new approach to healthcare, where quick and accurate diagnostics tests will be run wherever they are needed, without compromise.  

  • Industry Segment: Biotechnology, healthcare
  • Fort Collins, CO
  • Kris Buchanan and Dirk van den Boom
  • Founded: 2019
  • https://www.reddropdx.com/


NanoSpot.AI

NanoSpot.ai is leveraging a blood-spot-based (hemagglutination) approach and an artificial intelligence-driven mobile application to provide low-cost, accurate, objective, instrument-free, and quantitative diagnostic results to the point of care/home environment. NanoSpot.ai has now commercialized its first test on the platform for SARS-CoV-2 Total Antibodies and is actively developing several additional indications that will disrupt some of the largest markets in PoC/home-based diagnostics.

  • Industry Segment: Medical device, Diagnostics
  • Rian Wendling, Co-Founder
  • www.nanospot.ai
RSVP Here! Registration Required.
Innosphere Ventures | 320 E. Vine Drive, Fort Collins, CO 80524
Unsubscribe jkef...@larimer.org
Update Profile | Constant Contact Data Notice
Sent by em...@innosphereventures.org
Reply all
Reply to author
Forward
0 new messages